Ajooni Biotech, a leading animal healthcare, and animal feed company, plans to raise ₹29 crores through its rights issue. The rights issue will open for subscription on Wednesday. The funds raised through the issue will be used by the company for its expansion plans, market expansion, and for meeting general corporate objectives.
The rights issue priced at Rs 36 per share is available at a 30 percent discount to Tuesday's closing price. The rights issue will close on December 15. The company launched its IPO on the NSE Emerge platform in December 2017 and got shifted to the main board of NSE in May. The dairy-agri-oriented company will issue 4,83,60,313 fully paid-up equity shares.
Also Read: Layoffs: Retrenchment continues in companies, now PepsiCo is planning to sack hundreds of employees
In today’s rapidly evolving financial landscape, investment preferences among Indians are c
BAN vs SA T20 World Cup. In the 20th match of the T20 World Cup, South Africa defeated Bangladesh
Due to falling temperatures in the capital, a rise in pollution is being observed. With favourabl
There is tension on the India-Pakistan international border after India's Operation Sindoor on Pa
“We are facing a situation akin to war. Our supplies of crude oil, LPG, and LNG have been d
The war between Israel and Hamas continues from October 7. On the 26th day of the war, the Israel
The country's capital Delhi remains a gas chamber. In such a situation, the people of Delhi are i
Redmi is gearing up to expand its smartphone lineup with the launch of the much-anticipated Redmi
Comedian Kapil Sharma has entered the cinema halls with his film 'Zwigato'. This is the third fil
Shahrukh Khan has proved through his two films 'Pathan' and 'Jawaan' released this year, why he i
